Background illustration for clinical trials search

Paid Clinical Trials Rockville

Discover 2,411 paid clinical trials in Rockville, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 2,411

Psychological Treatments for Youth With Severe Irritability.

for

Irritability

Location: Bethesda MD

Sponsor: National Institute of Mental Health (NIMH)

Sex: All

Age: 8 - 17

Code: NCT02531893

Recruiting

Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL

for

Prostate Cancer, Biochemically Recurrent

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: Male

Age: 18+

Code: NCT05588128

Recruiting

Enzalutamide Implants (Enolen) in Patients With Prostate Cancer

for

Prostate Adenocarcinoma

Location: Bethesda MD, Baltimore MD, Richmond VA, Myrtle Beach SC,

Sponsor: Alessa Therapeutics Inc.

Sex: Male

Age: 21+

Code: NCT06257693

Phase1, Recruiting

VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B

for

Chronic Hepatitis B

Location: Bethesda MD

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Sex: All

Age: 18 - 65

Code: NCT06092333

Phase2, Recruiting

Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms

for

Endocrine Tumors, Thyroid Neoplasms, Parathyroid Neoplasms,

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 4+

Code: NCT01005654

Recruiting

Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease (CGD) With an Alemtuzumab, Busulfan and TBI-based Conditioning Regimen Combined With Cytokine (IL-6, +/- IFN-gamma) Antagonists

for

Chronic Granulomatous Disease

Location: Bethesda MD

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 4 - 65

Code: NCT05463133

Phase1, Phase2, Recruiting

Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma

for

Metastatic Melanoma, Advanced Locoregional Melanoma,

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT05155033

Phase2, Recruiting

A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome

for

Immunodeficiency, Hematopoietic Stem Cell Transplantation

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT05027945

Phase2, Recruiting

Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors

for

HIV

Location: Bethesda MD

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 70+

Code: NCT00029445

Recruiting

Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy

for

Somatostatin Receptor Positive,

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT06427798

Phase1, Phase2, Recruiting

Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma

for

Non-Hodgkin's Lymphoma, Diffuse Large B-Cell Lymphoma, DLBCL,

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04002947

Phase2, Recruiting

Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis

for

Severe Aplastic Anemia (SAA),

Location: Bethesda MD

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Sex: All

Age: 4 - 70+

Code: NCT03520647

Phase2, Recruiting

Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection

for

Malaria, Intestinal Worms, GI Protozoa, Echiniococcus,

Location: Bethesda MD

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 3+

Code: NCT00001645

Recruiting

Diagnosis of Pheochromocytoma

for

Pheochromocytoma, Endocrine Disease, Endocrine Diseases

Location: Bethesda MD

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Sex: All

Age: 3 - 70+

Code: NCT00004847

Phase1, Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

for

Carcinoma, Non-Small Cell Lung

Location: Bethesda MD, Silver Spring MD, Frederick MD, Towson MD,

Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06868277

Phase3, Recruiting

Inherited Reproductive Disorders

for

Genetic Disorder, Infertility, Hypogonadism, Amenorrhea

Location: Bethesda MD, Research Triangle Park NC

Sponsor: National Institute of Environmental Health Sciences (NIEHS)

Sex: All

Age: 0 - 70+

Code: NCT01500447

Recruiting

Fecal Microbiota Transplantation for Chronic Granulomatous Disease-Associated Colitis

for

Chronic Granulomatous Disease-associated Colitis

Location: Bethesda MD

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 10 - 60

Code: NCT05333471

Phase1, Phase2, Recruiting

Diagnosis and Treatment of Leishmania Infections

for

Kinetoplastid, Skin Diseases, Parasitic, Parasitic Diseases,

Location: Bethesda MD

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 3 - 70+

Code: NCT00344188

Recruiting

Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)

for

Multiple Sclerosis

Location: Bethesda MD

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 70+

Code: NCT03109288

Phase1, Phase2, Recruiting

Study of Alkaptonuria

for

Alkaptonuria

Location: Bethesda MD

Sponsor: National Human Genome Research Institute (NHGRI)

Sex: All

Age: 2 - 70+

Code: NCT00005909

Recruiting

Paid Clinical Trials Rockville

Filter results

Psychological Treatments for Youth With Severe Irritability.

Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL

Enzalutamide Implants (Enolen) in Patients With Prostate Cancer

VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B

Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms

Interested in new trials?

Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease (CGD) With an Alemtuzumab, Busulfan and TBI-based Conditioning Regimen Combined With Cytokine (IL-6, +/- IFN-gamma) Antagonists

Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma

A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome

Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors

Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy

Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma

Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis

Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection

Diagnosis of Pheochromocytoma

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

Inherited Reproductive Disorders

Fecal Microbiota Transplantation for Chronic Granulomatous Disease-Associated Colitis

Diagnosis and Treatment of Leishmania Infections

Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)

Study of Alkaptonuria